Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00148512
Status:
COMPLETED
Last Update Posted:
2013-10-29
First Post:
2005-09-07
Brief Title:
A Randomized Double-blind Placebo-controlled Five Parallel Groups Efficacy and Safety Study of NS 2330 Tesofensine 0125 mg 025 mg 05 mg and 10 mg Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-03
Start Date Type:
None
Primary Completion Date:
2005-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-02
Completion Date Type:
None
First Submit Date:
2005-09-07
First Submit QC Date:
September 7 2005
Study First Post Date:
2005-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-10-28
Last Update Post Date:
2013-10-29
Last Update Post Date Type:
ESTIMATED